Clinical Trial Update: Exploratory Study of Coronary Flow Reserve Measurements, a Non-Invasive Method for Coronary Function Measurements [EARLY_Phase 1]

View source ↗

Summary

Exploratory Phase 1 trial assessing coronary flow reserve measurements as a non-invasive method for evaluating coronary function; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease

Snippet

Sponsor: AstraZeneca | Conditions: Atherosclerosis, Inflammatory Activity in Coronary Arteries | EARLY_Phase 1 | Status: COMPLETED